ACS Medicinal Chemistry Letters : Impact Factor & More
eISSN: 1948-5875pISSN: 1948-5875
Share this on:
Aims and Scope of ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA). Less
Key Metrics
CiteScore 
6.6
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
0.93
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | AMER CHEMICAL SOC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in ACS Medicinal Chemistry Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ACS Medicinal Chemistry Letters
Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer
- 31 Jul 2026
- ACS Medicinal Chemistry Letters
Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders
- 15 Jul 2026
- ACS Medicinal Chemistry Letters
High-Throughput CETSA Identifies Small Molecule Modulators of ILT3 (LILRB4) with Functional Activity in Human iPSC-Derived Microglia for Alzheimer's Disease.
- 9 Jul 2026
- ACS medicinal chemistry letters
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.
- 9 Jul 2026
- ACS medicinal chemistry letters
Novel Tetrahydroquinazoline Derivatives for Treating HIV Infection or AIDS or AIDS Related Complex.
- 9 Jul 2026
- ACS medicinal chemistry letters
Correction to "Mechanistic Insights from Differences in the Aggregate Morphologies of Amphotericin B and Its Less Toxic Variant Am-2-19".
- 9 Jul 2026
- ACS medicinal chemistry letters
Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer
- 31 Jul 2026
- ACS Medicinal Chemistry Letters
Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders
- 15 Jul 2026
- ACS Medicinal Chemistry Letters
High-Throughput CETSA Identifies Small Molecule Modulators of ILT3 (LILRB4) with Functional Activity in Human iPSC-Derived Microglia for Alzheimer's Disease.
- 9 Jul 2026
- ACS medicinal chemistry letters
Targeting Histone Acetyltransferases EP300/CBP by Novel Proline-Based PROTAC Degraders.
- 9 Jul 2026
- ACS medicinal chemistry letters
Novel Tetrahydroquinazoline Derivatives for Treating HIV Infection or AIDS or AIDS Related Complex.
- 9 Jul 2026
- ACS medicinal chemistry letters
Correction to "Mechanistic Insights from Differences in the Aggregate Morphologies of Amphotericin B and Its Less Toxic Variant Am-2-19".
- 9 Jul 2026
- ACS medicinal chemistry letters
FAQs on ACS Medicinal Chemistry Letters
How long has ACS Medicinal Chemistry Letters been actively publishing? 
What is the publishing frequency of ACS Medicinal Chemistry Letters?
How many articles did ACS Medicinal Chemistry Letters publish last year?
What is the eISSN & pISSN for ACS Medicinal Chemistry Letters?
What is Citescore for ACS Medicinal Chemistry Letters?
What is SNIP score for ACS Medicinal Chemistry Letters?
What is the SJR for ACS Medicinal Chemistry Letters?
Who is the publisher of ACS Medicinal Chemistry Letters?
